Regenerative craniofacial implant manufacturer OssDsign has amassed $19.7m altogether as it prepares to take its products based on Karolinska and Uppsala university research into new markets.

OssDsign, a Sweden-based developer of regenerative implants founded on research from Karolinska University Hospital and Uppsala University, closed a SKr64m ($6.9m) private placement on Tuesday backed by investment manager Alto Invest. The round also featured unnamed Swedish private investors. Founded in 2011 as Oss-Q, OssDsign designs and manufactures healing implants for bone defects made from…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.